Your AAV partner
from bench
to clinic

InnovAAVector s.r.l. is a CDMO specialized in the design, development and GMP production of AAV viral vectors to enable novel cell and gene therapies from discovery to clinical trials.

Discover more

Authorized by AIFA for the production of investigational medicinal products for gene therapy, from production, characterization, release and packaging

ESGCT Congress

InnovaVector will be attending the ESGCT congress that will take place in Rome, IT, on 22nd to 25th October, 2024

MESA Congress

InnovaVector will be attending the Cell&Gene meeting on the MESA on October 7-9, 2024 in Phoenix, AZ.